100X-logo
menu
Home
Portfolio
Class 08
About Us
Team
iSafe
Investor Hub
arrow-icon
Founders' Hub
arrow-icon
Partners
arrow-icon
News and Views
arrow-icon
Contact Us
100X.VC Team
Written by various collaborators within Team 100X.VC
Latest News
the-hindu-srm-ap-student-s-startup-...
Read more
ibs-intelligence-indian-fin-tech-in...
Read more
the-hindu-businessline-mumbai-based...
Read more
DCode Care Raises Seed Round Co-led By Inflection Point Ventures And PointOne Capital
calendar
Aug 19, 2021

DCode Care

announced that it has raised a Seed round co-led by angel investment platform Inflection Point Ventures and PointOne Capital.

The infusion of capital comes six months after the firm raised Pre-Seed financing from early-stage venture firm 100X.VC  and a clutch of angel investors.

DCode Care helps critical illness patients discover the right treatment and healthcare providers basis their condition and budget. Currently servicing Cancer patients, the startup leverages proprietary technology to bring transparency in medical treatments. The funds raised will be utilized for marketing and business development, expansion to cities beyond Bengaluru, and product development to deliver a personalized tech-driven experience for patients.

 “We are on a mission to empower patients with expert guidance on correct treatment at the right prices. We are pleased to partner with IPV in our vision to create an impact in the space of critical illness management. IPV has opened its wide network of portfolio companies and investor mentors for us. We look forward to leveraging the knowledge pool within the IPV system to grow,” explained Preeti Veenam, founder, DCode Care.

Read more here: DCode Care Raises Seed Round Co-led By Inflection Point Ventures And PointOne Capital

logo-footer
100X.VC is the first VC to invest in early stage startups using founder friendly India SAFE Notes.
Send Your pitches to us at:
[email protected]
For other queries, please contact us at:
[email protected]
Portfolio
Class 08
About Us
Team
iSafe
Partners
Investor Hub
Founders Hub
News and Views
Contact Us
© 2000-2021, All Rights Reserved